Table 1.

Demographics and Bivariate Analysis of Participants With Prehypertension During Visit 2 in the ARIC Study (N = 2,334) and Percentage of Each Group Developing Hypertension and Coronary Heart Disease

Development of HypertensionDevelopment of CHD/CHD Death
VariablePopulation No. (%)%χ2P Value%χ2P Value
ARIC = Atherosclerosis Risk in Communities; CHD = coronary heart disease.
Age category<.001.014
    48–57 y1,176 (50.4)53.09.6
    58–67 y1,158 (49.5)63.212.9
Sex<.001<.001
    Male1,127 (48.3)53.217.0
    Female1,207 (51.7)62.65.8
Race<.001.005
    Nonblack1,863 (79.8)56.012.2
    Black471 (20.2)66.37.6
Diabetes.052<.001
    Yes117 (5.0)67.324.0
    No2,217 (95.0)57.510.5
Low-density lipoprotein cholesterol.110.075
    ≤160 mg/dL1,839 (78.8)57.010.5
    >160 mg/dL495 (21.2)61.413.4
Maastricht Questionnaire score.045.019
    Low (0–7)773 (33.1)56.710.1
    Moderate (8–12)756 (32.4)55.19.5
    High (>12)805 (34.5)61.613.7
Spielberger Trait Anger Scale score.018.011
    Low (10–14)901 (38.6)59.99.8
    Moderate (15–21)1,272 (54.5)55.611.5
    High (>21)161 (6.9)66.718.0
    ≥2.51,351 (57.9)56.810.8
Body mass index.007.362
    ≤301,671 (71.6)56.310.8
    >30663 (28.4)62.812.2
Exercise hours per week.168.484
    <2.5983 (42.1)59.811.8
    ≥2.51,351 (57.9)56.810.8
Current smoking status.349.021
    Yes502 (21.5)60.014.0
    No1,832 (78.5)57.510.4
Lubben Social Network score.796.220
    Low (0–35)707 (30.3)57.712.5
    Moderate (36–39)728 (31.2)57.610.0
    High (>39)899 (38.5)59.78.8